Drug Profile
Diperdipine
Alternative Names: YS 201Latest Information Update: 16 Nov 2000
Price :
$50
*
At a glance
- Originator Medea Research; SIR International
- Developer SIR International
- Class Antiarrhythmics; Antihypertensives; Dihydropyridines; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 16 Nov 2000 Discontinued-II in Angina pectoris in France (IV)
- 16 Nov 2000 Discontinued-Unspecified phase in Hypertension in France (PO)
- 17 Jan 1997 Phase-II clinical trials for Angina pectoris in France (IV)